Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Medicines beyond barriers

Videos
medicines beyond barriersG2B

At Gate2Brain, we have found the key to unlocking the gate to the brain . We have developed a unique shuttle technology to cross the blood-brain barrier. A technology based on a set of peptides to allow the different therapeutic agents to reach the brain in a non-invasive form.

Our first target is pediatric high grades gliomas which is a group of non-curable and fast acting CNS disorders. Gate2Brain’s technology can be applied to other molecules and to other brain diseases. Gate2Brain holds the potential to treat some of the most devastating human diseases.

We are working to bring this technology to the market and go beyond barriers.

 

 

June 29, 2022/by noticias
Tags: Biotech, Innovation, medicinesbeyondbarriers, pediatriccancer, research
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/06/Copia-de-EmpresaCultura-CREO.png 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-06-29 10:17:172022-06-29 10:35:02Medicines beyond barriers
You might also like
‘Tractor’ proteins that carry drugs to the brain as therapy for incurable pediatric cancer
Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansiónTHIS IS HOW A DRUG IS TOWED TO THE BRAIN
It’s Gate2Brain second anniversary!! 🎂 The creativity, work and dedication of Gate2Brain's team can only be matched with its desire to bring medicines beyond barriers.Gate2BrainGate2Brain second anniversary
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.Gate2Brain will be attending The Investment Readiness Series
EITHealth Catapult 2022eithealthGate2Brain semifinalist of EITHealth’s Catapult 2022
talento científicotalento cientificoFounding a company in times of pandemic
2 year anniversaryGate2BrainGate2Brain 2 year highlights at a glance

CATEGORIES

  • Clipping
  • Events
  • Media
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach”, organized by Foment del Treball.Foment del TreballThe innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach.March 23, 2023 - 08:54
  • G2B at 4YFN 2023G2BGate2Brain at 4YFN-MWC23March 3, 2023 - 08:24
  • Gate2Brain at TransfiereG2BG2B at Transfiere 2023February 17, 2023 - 07:45
  • 📢 On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven Dr. Mulfinger (Dana_positive maternal health), and Diana Ballart (The Smart Lollipop) in the i4kids Closing Event 2022, sharing achievements and failures of entrepreneurs in #pediatric and maternal #healthcare.i4kidsi4kids Closing Event 2022December 7, 2022 - 12:37
  • WomenStartupAwards, in the "Inspiration" category.WomeninTechSpainFinalist of Women Startup AwardsNovember 15, 2022 - 17:46

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • Barcelona to host BIO-Europe Spring 2024 March 23, 2023 biocat
  • 4YFN 2023 sees record turnout, surpassing all expectations March 6, 2023 biocat
  • European health clusters tackle sector’s main challenges in international framework February 24, 2023 biocat
  • Sector experts review main strategic challenges facing BioRegion of Catalonia February 23, 2023 biocat
  • Different health clusters in Ukraine know about the BioRegion thanks to Biocat February 23, 2023 biocat
  • Biocat and Alira Health launch market access program for BioRegion startups February 23, 2023 biocat
  • CRAASH Barcelona celebrates 5th anniversary February 23, 2023 biocat
  • Highlights: New historic record for investment in the BioRegion, new funding, more acquisitions, and ground-breaking research into strokes February 23, 2023 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Gate2Brain semifinalist of EITHealth’s Catapult 2022EITHealth Catapult 2022eithealthGate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}